145
Participants
Start Date
October 30, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
January 31, 2027
ZW191
Administered intravenously
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
NEXT Virginia, Fairfax
RECRUITING
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
RECRUITING
Stephenson Cancer Center, Oklahoma City
RECRUITING
NEXT Oncology, San Antonio
RECRUITING
National University Health System (NUHS) - National University Cancer Institute Singapore (NCIS), Singapore
RECRUITING
National Cancer Centre Singapore, Singapore
RECRUITING
Yale University, New Haven
RECRUITING
Linear Clinical Research, Nedlands
RECRUITING
Royal North Shore Hospital Northern Sydney Cancer Centre, St Leonards
RECRUITING
National Cancer Center Hospital East, Kashiwa-shi
RECRUITING
Saitama Medical University International Medical Center, Saitama
RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
The Cancer Institute Hospital of JFCR, Tokyo
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
Zymeworks BC Inc.
INDUSTRY